Laparoscopic lymph node dissection: pelvic and retroperitoneal

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Laparoscopic procedures have rapidly advanced in urology since the 1990s.
• Laparoscopic pelvic lymph node dissection (LPLND) for prostate cancer staging was an early, widely accepted application.
• The field has since seen the development and acceptance of numerous other laparoscopic urologic procedures.

Purpose of the Study:

• To discuss the technique of laparoscopic pelvic lymph node dissection for staging prostate cancer.
• To explore potential applications of LPLND in bladder, urethral, and penile cancers.
• To describe laparoscopic retroperitoneal lymph node dissection for testicular cancer.

Main Methods:

• Review of established laparoscopic techniques in urologic oncology.
• Discussion of indications for various laparoscopic lymph node dissections.
• Summary of postoperative outcomes for discussed procedures.

Main Results:

• Laparoscopic pelvic lymph node dissection is a key staging tool for prostate cancer.
• Laparoscopic retroperitoneal lymph node dissection is utilized for testicular cancer.
• The application of laparoscopy is expanding to other urologic malignancies.

Conclusions:

• Laparoscopic techniques are integral to modern urologic oncology.
• Laparoscopic lymph node dissection offers viable staging and treatment options for various urologic cancers.
• Further applications and refinements in laparoscopic urologic surgery are anticipated.